{"nctId":"NCT04253626","briefTitle":"Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia","startDateStruct":{"date":"2021-01-21","type":"ACTUAL"},"conditions":["Pregnancy Related","Anemia, Iron Deficiency"],"count":83,"armGroups":[{"label":"Intravenous iron","type":"EXPERIMENTAL","interventionNames":["Drug: Ferumoxytol Injection [Feraheme]"]},{"label":"Oral iron","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ferrous Sulfate"]}],"interventions":[{"name":"Ferumoxytol Injection [Feraheme]","otherNames":[]},{"name":"Ferrous Sulfate","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Pregnant women 18 years old and above\n2. Hemoglobin \\< 11 g/dL, serum ferritin \\< 30 ug/dL and or transferrin saturation (TSAT) \\< 20%\n3. Between 24-34 weeks' pregnancy\n4. Singleton pregnancy\n5. Receiving prenatal care at Stanford/LPCH OB clinic and planning to deliver at LPCH\n6. Hemodynamically stable\n\nExclusion Criteria:\n\n1. Patients unable to give informed consent\n2. Known allergy/hypersensitivity to IV iron\n3. Inflammatory Bowel Disease or history of gastric bypass surgery\n4. Dialysis-dependent Chronic Kidney Disease/ ESRD\n5. Known Hemoglobinopathies such as sickle cell disease, beta-thalassemia, alpha thalassemia\n6. Folate/Vitamin B12 deficiency\n7. Known malignancy\n8. Medication allergy to Tylenol (acetaminophen)\n9. Hemoglobin above 12 or less than 7 g/dL\n10. Patients with complex past medical histories which may include history of multiple medication allergies (greater than 2 allergies), connective tissue disorder, etc.\n11. Diagnosis of placenta previa","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Median Change in Hemoglobin Value Before and After Intervention","description":"Hemoglobin is measured as g/dL at enrollment and after the study intervention","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.95","spread":null},{"groupId":"OG001","value":"11.45","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Discontinued Treatment","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Serious Adverse Events Associated With Treatment","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Need Blood Transfusion Postpartum","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Short Form (SF-)36 General Health Symptom Score","description":"Score range: 0 to 100 (lower scores indicate more severe symptoms, higher scores correspond to fewer symptoms)","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"63","spread":null},{"groupId":"OG001","value":"63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Short Form (SF-)36 Physical Functioning Score","description":"Score range: 0 to 100 (lower scores indicate less physical function, higher scores correspond to more physical function).","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70","spread":null},{"groupId":"OG001","value":"70","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Short Form (SF-)36 Role Limitations Due to Physical Health Score","description":"Score range: 0 to 100 (lower scores indicate more limitations, higher scores correspond to fewer limitations).","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null},{"groupId":"OG001","value":"50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Short Form (SF-)36 Energy/Fatigue Score","description":"Score range: 0 to 100 (lower scores indicate more fatigue, higher scores correspond to more energy).","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"40","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":["Constipation","Nausea/ Vomiting","Abdominal pain","Edema/ Swelling of limbs","Body aches/ pains"]}}}